BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SenzaGen - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://senzagen.com
X-WR-CALDESC:Events for SenzaGen
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200903T160000
DTEND;TZID=Europe/Stockholm:20200903T163000
DTSTAMP:20200825T083659Z
CREATED:20200818T102204Z
LAST-MODIFIED:20200825T083659Z
UID:24195-1599148800-1599150600@senzagen.com
SUMMARY:New session: Webinar GARD™skin Dose-Response
DESCRIPTION:Given the huge interest in our previous webinar on GARDskin Dose-Response\, we are pleased to offer you a new opportunity to get to know this novel in vitro test. \nThe webinar will start with a recorded presentation followed by a live Q&A session. You will learn how the assay works and how it can help you with skin sensitizing potency ranking of candidate ingredients and early decision-making during product development.\n \n\nKey takeaways\n\nHow GARDskin Dose-Response works.\nHow the readouts correlate with LLNA EC3 values and human sensitizing potency categories.\nExamples of how the readout can be used depending on the customer-specific needs.\n\n  \n \nFeatured Speaker\n \nAndy Forreryd\, PhD\, SenzaGen AB \nGARDskin Dose-Response at a glance\nGARDskin Dose-Response is a novel in vitro test for quantitative potency assessment of chemicals\, adapted from GARDskin. \nGARDskin Dose-Response provides an estimated threshold concentration for a test substance to induce skin sensitizing effects (higher equaling a lower potency and vice versa). This threshold concentration can be used for skin sensitizing potency ranking of candidate ingredients and early decision-making during product development. \nAdditionally\, the readout can be extrapolated to a correlating LLNA EC3 value\, which is traditionally used to measure skin sensitizing potency of chemicals. Depending on the customer needs\, it can also be extrapolated to a correlating Basketter Human Potency category (1-6) and/or GHS/CLP classification (1A or 1B) with high statistical significance. \n\nRead more\n\n\n\n  \n\nWhat to know before attending the webinar?\nThe webinar will last around 30 minutes\, followed by a live Q&A. \nNo required technical background on genomics\, machine learning or programming. \nIf you can’t attend\, still make sure to register! All registrants will receive the webinar materials afterwards.
URL:https://senzagen.com/event/new-session-gardskin-dose-response/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/08/Webinar_Banner_Linkedin.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200909T150000
DTEND;TZID=Europe/Stockholm:20200909T163000
DTSTAMP:20200904T104225Z
CREATED:20200903T074926Z
LAST-MODIFIED:20200904T104225Z
UID:24675-1599663600-1599669000@senzagen.com
SUMMARY:MVA\, MedTech Network
DESCRIPTION:MVA Medtech Network gathers the region’s medtech industry to create new partnerships and business opportunities. Joining the network is free of charge but is limited to Medicon Valley Alliance members. However\, non-member organizations and companies are welcome to attend one network event to evaluate if being part of the network is relevant. If so\, becoming a member of Medicon Valley Alliance will automatically allow you to join the medtech network. \nProgram\n \n\n\n\n14.50-15.00\nOnline platform open for registering participants\n\n\n15.00-15.10\nWelcome\nPetter Hartman\, CEO\, Medicon Valley Alliance\n\n\n15.10-15.30\n21st Century Toxicology: Alternatives for Medical Device Testing\nKelly P. Coleman\, Distinguished Toxicologist\, Medtronic PLC\n\n\n15.30-15.40\nComputational methods\nCarsten Baun Senholt\, CTO\, Saxocon\n\n\n15.40-15.50\nNew in vitro test methods\nRose-Marie Jenvert\, Product Manager GARD applications\, Senzagen\n\n\n15.50-16.10\nConsiderations and points of interest of notified bodies for medical devices with regard to in-silico approaches for toxicological risk assessment\nJulian Kirch\, General Essential Modules – TÜV SÜD Product Service GmbH\n\n\n16.10-16.15\nConclusions\nCompany TBC
URL:https://senzagen.com/event/mva-medtech-network/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/MVA.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200915T160000
DTEND;TZID=Europe/Stockholm:20200915T163000
DTSTAMP:20200716T065215Z
CREATED:20200716T065215Z
LAST-MODIFIED:20200716T065215Z
UID:24122-1600185600-1600187400@senzagen.com
SUMMARY:Joint webinar: Your Guide to GARD® – New generation skin sensitisation testing technologies explained
DESCRIPTION:SenzaGen have partnered with XCellR8 to bring you this half hour webinar to explain more about how the GARD methods work\, from determining potency to animal-product-free solutions. \n \nYou will learn\n\nHow GARD assays can be used for the safety assessment of chemicals\, formulations and finished products\nHow the new animal-product-free version of GARDskin can help support vegan tested claims\nHow GARD is meeting the challenges of skin sensitisation potency and dose-response\n\nSpeakers\n         \nDr Carol Treasure\, XCellR8     Dr Andy Forreryd\, SenzaGen\nWho should attend?\nThis webinar is designed for anyone involved in cosmetic product development\, including formulators\, regulatory managers\, safety assessors and toxicologists. You don’t need a technical background on genomics\, machine learning or programming.
URL:https://senzagen.com/event/joint-webinar-your-guide-to-gard-new-generation-skin-sensitisation-testing-technologies-explained/
ATTACH;FMTTYPE=image/jpeg:https://senzagen.com/wp-content/uploads/2020/07/Sep-15_Banner_event-page.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200922T130000
DTEND;TZID=Europe/Stockholm:20200922T140000
DTSTAMP:20200922T091143Z
CREATED:20200922T091043Z
LAST-MODIFIED:20200922T091143Z
UID:24871-1600779600-1600783200@senzagen.com
SUMMARY:OpenTox Virtual Conference
DESCRIPTION:13.00 Session 5. Cosmetics Assessment \n\nChair: Hanan Osman-Ponchet (PKDERM)\nTalk: Andy Forreryd\,  Dose-response analysis in GARD for assessment of skin sensitizer potency
URL:https://senzagen.com/event/opentox-virtual-conference/
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/OT-banner.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20200924T080000
DTEND;TZID=Europe/Stockholm:20200925T170000
DTSTAMP:20200923T075910Z
CREATED:20200903T075308Z
LAST-MODIFIED:20200923T075910Z
UID:24681-1600934400-1601053200@senzagen.com
SUMMARY:Biocompatibility testing in Medical Devices Conference 2020
DESCRIPTION:Biocompatibility testing in Medical Devices Conference 2020 will give you the unique opportunity to discuss the most pressing issues and meet the representatives of the biggest companies and leaders from Biocompatibility and Medical Device Industries \nBiocompatibility testing in Medical Devices Conference 2020 is a great platform for learning\, exchanging opinions\, and expanding one’s network enabled by live presentations followed by dynamic questions & answers sessions as well as panel discussions and workshops with keynote speakers. \n\nSpeaker: PhD Rose-Marie Jenvert\, SenzaGen:\nIn vitro alternatives for assessment of skin irritation and skin sensitization potential of chemicals in medical devices
URL:https://senzagen.com/event/biocompatibility-testing-in-medical-devices-conference-2020/
LOCATION:Prague
ATTACH;FMTTYPE=image/png:https://senzagen.com/wp-content/uploads/2020/09/Biocom.png
END:VEVENT
END:VCALENDAR